Compare KRRO & ESP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRRO | ESP |
|---|---|---|
| Founded | 2014 | 1928 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.0M | 171.4M |
| IPO Year | 2019 | 1995 |
| Metric | KRRO | ESP |
|---|---|---|
| Price | $13.47 | $59.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 1 |
| Target Price | $34.80 | ★ $64.00 |
| AVG Volume (30 Days) | ★ 266.1K | 11.2K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 1.77% |
| EPS Growth | N/A | ★ 31.88 |
| EPS | N/A | ★ 1.75 |
| Revenue | $6,392,000.00 | ★ $43,950,872.00 |
| Revenue This Year | N/A | $10.30 |
| Revenue Next Year | N/A | $10.00 |
| P/E Ratio | ★ N/A | $32.34 |
| Revenue Growth | ★ 181.46 | 13.46 |
| 52 Week Low | $5.20 | $25.04 |
| 52 Week High | $55.89 | $62.15 |
| Indicator | KRRO | ESP |
|---|---|---|
| Relative Strength Index (RSI) | 60.38 | 56.08 |
| Support Level | $12.17 | $52.83 |
| Resistance Level | $14.96 | $61.58 |
| Average True Range (ATR) | 0.99 | 2.23 |
| MACD | 0.31 | 0.16 |
| Stochastic Oscillator | 62.16 | 82.52 |
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.
Espey Manufacturing & Electronics Corp is a power electronics design and OEM manufacturing company delivering products for military and severe environment applications. Its products include power supplies, power converters, filters, power transformers, magnetic components, power distribution equipment, UPS systems, and antennas. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power. Espey services include design and development to specification, build to specifications provided by the customer, build to print, design services, design studies, environmental testing services, metal fabrication, painting services, and development of automatic testing equipment.